NYSE:ZTSPharmaceuticals
Zoetis (ZTS) Stock May Look Reasonable Following Its CFO And COO Appointment
Zoetis stock has had a difficult run, with the share price down about 59.1% over the past five years, yet the current valuation checks still lean toward the shares looking cheap on several measures.
Over the past five years, Zoetis has delivered a share price decline of about 59.1%, which puts long term holders firmly in negative territory and raises questions about what the current price already reflects.
The recent appointment of James Saccaro as Chief Financial Officer and Chief Operating...